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ABSTRACT
We presented a 38-year-old woman suffering from acute 
cerebral infarction due to arteritis limited to bilateral 
internal carotid arteries without a condition of giant cell 
arteritis or granulomatosis with polyangitis. Our case 
is unprecedented and characterized by a young woman 
with wall enhancement in the internal carotid arteries on 
contrast-enhanced magnetic resonance imaging (MRI), 
therapeutic effects of steroids, and positive status for hu-
man leucocyte antigen-B39, -B51 and -DR4. These dis-
ease characteristics were not in accordance with existing 
diagnostic criteria of vasculitis, such as Takayasu’s arte-
ritis, giant cell arteritis, granulomatosis with polyangii-
tis, and Behcet’s disease. We suggested consideration of 
a novel “isolated internal carotid arteritis” disease con-
cept.
Key words    arteritis; carotid artery; internal; magnetic 
resonance imaging; vasculitis 
Here, we report a case of arteritis that was limited to the 
internal carotid artery (ICA), presenting a challenge to 
existing disease concepts. The first International Chapel 
Hill Consensus Conference on the Nomenclature of Sys-
temic Vasculitides (CHCC) proposed names and defini-
tions for the most common forms of vasculitis in 1994, 
and these were then revised at the second International 
CHCC in 2012.1 Although atypical cases exist, no cases 
of arteritis limited to the ICA have been reported. The 
present case suffered repeated strokes within a short pe-
riod, and contrast-enhanced magnetic resonance imag-
ing (MRI) revealed wall enhancement in bilateral ICAs. 
Subsequent administration of prednisolone and anti-
thrombotic therapy successfully ameliorated the clinical 
conditions.
PATIENT REPORT
A 38-year-old woman presented with pain in the extrem-
ities and fluctuating left-sided weakness in the beginning 
of August 2011. At the end of August, she presented with 
right-sided weakness and was admitted to our hospital. 
She had no past medical history and was not taking any 
prescription medications. Family history pertaining to 
her mother revealed high blood pressure and pertaining 
to her father revealed depression. Her blood pressure was 
154/108mmHg and her body temperature was 37.2 °C. 
Physical examinations revealed tenderness in both arms, 
although no arterial bruits or prominent temporal arter-
ies were evident. Neurological examinations showed im-
paired consciousness (Glasgow Coma Score, E3V4M6), 
left hemispatial neglect, ocular deviation to the right, left 
supranuclear facial palsy, dysarthria and breathy voice, 
left flaccid hemiplegia, right mild hemiparesis, left deep 
and mild superficial hypoesthesia with dysesthesia of the 
left side of the body, hyperactive tendon reflexes in the 
right upper and lower limbs, and a right Babinski’s sign. 
Urine testing yielded normal results, whereas laborato-
ry data revealed elevated leukocyte counts (9800 cells/
μL), erythrocyte sedimentation rates (ESR; 45 mm/h), 
C-reactive protein levels (0.32 mg/dl) and CH50 titers 
(50 U/mL). Tests of blood coagulation and fibrinolysis 
yielded normal results. However, serotyping of human 
leucocyte antigen (HLA) class I and II revealed that the 
patient was positive for A2, A24, B39, B51, DR4 and 
DR11, and tests for serum autoantibodies, including cy-
toplasmic and perinuclear anti-neutrophil cytoplasmic 
antibodies, were all negative. Levels of vitamins, amino 
acids, alpha-galactosidase, tumor markers, and markers 
of infection, including tuberculosis, were all normal. Ce-
rebrospinal fluid testing also revealed normal results.
 Onset at a young age and absence of risk factors 
indicated the presence of an uncommon cause of stroke. 
On admission, magnetic resonance angiography (MRA; 
249
Isolated internal carotid arteritis
Fig. 1. Magnetic resonance imaging, magnetic resonance angiography, and digital subtraction angiography.
A) MRA on admission showed multiple stenosis and distal occlusion (arrows) in the left ICA, severe stenosis (arrows) in the distal right 
ICA, and bilateral signal loss in the ACA and MCA.
B) Diffusion-weighted MRI on admission showed acute ischemic infarcts in bilateral frontal lobes.
C) Diffusion-weighted MRI on day 17 of hospitalization showed recurrent infarcts in the right frontal and temporal lobes and left corona 
radiata.
D) Right CCA angiography of the cervical portion on day 15 of hospitalization showed severe stenosis (arrow) of the supraclinoid segment 
and multiple arterial wall irregularities in the right ICA, cross-fl ow into the left ACA and MCA via the anterior communicating artery, 
and no abnormality in the branches of the right external carotid artery.
E) Left CCA angiography of the cervical portion on day 15 of hospitalization showed a diffusely thin left ICA with multiple arterial wall 
irregularities, and occlusion (arrow) just distal to the ophthalmic artery origin. No abnormalities indicated Moyamoya disease, fi bromus-
cular dysplasia, dissection, or intracranial arteritis, and no abnormalities were evident in the branches of the left external carotid artery.
ACA, anterior cerebral artery; CCA, common carotid artery; ICA, internal carotid artery; MCA, middle cerebral artery; MRA, magnetic 
resonance angiography; MRI, magnetic resonance imaging.
Fig. 1A) showed occlusion of the left ICA and severe ste-
nosis of the right ICA. Moreover, MRI (Fig. 1B) demon-
strated acute ischemic infarcts in bilateral frontal lobes, 
and carotid ultrasonography showed the absence of mac-
aroni signs in bilateral common carotid arteries (CCAs), 
reducing end-diastolic velocity in the left CCA, thicken-
ing of the wall to the right ICA, and complete absence of 
color-fl ow signals of the cervical portion in the left ICA. 
The anti-coagulant argatroban and the neuroprotective 
agent edaravone were administered to improve the levels 
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Fig. 2. Contrast-enhanced T1-weighted MRI.
A1, A2), admission; B1, B2, B3), day 23 of hospitalization; C1, C2, C3), at the time of discharge after prednisolone treatment. 
A1) Retrospective contrast-enhanced T1-weighted MRI showed wall enhancement as in B1. A2) Magnifi ed view of A1.
B1) Contrast-enhanced T1-weighted MRI showed wall enhancement in bilateral ICAs and bilateral wall thickening in the ICA and distal 
CCA. B2) Magnifi ed view of B1. B3) Cervical MRA showed stenosis (arrows) in the left ICA.
C1) Contrast-enhanced T1-weighted MRI showed persistent wall enhancement in bilateral ICAs. C2) Magnifi ed view of C1. C3) MRA 
showed bilateral improvements of signal intensity in the ACA and MCA.
ACA, anterior cerebral artery; CCA, common carotid artery; ECA, external carotid artery; ICA, internal carotid artery; MCA, middle 
cerebral artery; MRA, magnetic resonance angiography; MRI, magnetic resonance imaging.
of consciousness and ameliorate the right hemiparesis. 
Subsequent N-isopropyl-p-(123I) iodoamphetamine sin-
gle photon emission computed tomography (123I-IMP 
SPECT) showed hypoperfusion in the territory of the 
bilateral anterior and middle cerebral arteries, with left 
dominance.
 On the 5th day of hospitalization, progressive right 
hemiparesis occurred and brain computed tomography 
(CT) showed hemorrhagic infarction in the left anterior 
lobe. Hence, argatroban was discontinued and the pa-
tient’s condition was stabilized. Cerebral angiography on 
the 15th day of hospitalization (Figs. 1D and E) revealed 
left ICA occlusion and no abnormalities in branches of 
external carotid arteries. No indicators of Moyamoya 
disease, fibromuscular dysplasia, dissection or intra-
cranial arteritis were observed. Although cilostazol 
therapy (200 mg/day, BID) was initiated to prevent re-
current stroke, the patient showed low fever, impaired 
consciousness and progression of bilateral hemiparesis. 
MRI showed recurrent infarcts in the right frontal and 
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temporal lobes and left corona radiata suggesting embol-
ic infarction on the 17th day of hospitalization (Fig. 1C). 
Impaired consciousness and right hemiparesis improved 
after resuming argatroban and edaravone, although the 
patient presented with gradually increasing fever, ten-
derness of bilateral carotid arteries, bilateral headache, 
odynophagia, arthralgia and an elevated erythrocyte 
sedimentation rate (ESR) (97 mm/h) on the 22nd day of 
hospitalization. Contrast-enhanced MRI and MRA (Figs. 
2B1–B3) revealed wall enhancement in bilateral ICAs 
and wall thickening in bilateral ICAs and distal CCAs, 
warranting diagnosis of arteritis. Positron emission to-
mography–computed tomography, 3-dimensional CT an-
giography, and sonography showed no abnormal lesions 
in arterial or venous systems. Moreover, a superficial 
temporal artery (STA) biopsy showed only slight intimal 
thickening without inflammation, with no evidence of 
giant cell arteritis (GCA). Ophthalmologic and derma-
tologic consultation detected no abnormalities such as 
fundus abnormalities, uveitis, temporal artery distention, 
oral aphtha and skin lesions., implying particular immu-
nological diseases including Behcet’s disease. Although 
symptoms stabilized with argatroban therapy during the 
acute stage, stroke recurred following discontinuation of 
this treatment and initiation of cilostazol therapy. Hence, 
arteritis was the suspected cause of stroke recurrences, 
and oral prednisolone therapy (0.6 mg/kg body weight/
day, 30 mg/day) was administered on the 36th day of 
hospitalization according to the guidelines for GCA and 
Takayasu’s arteritis (TAK). Heparin infusions (10,000 U/
day) were then initiated and the dose was adjusted based 
on activated partial thromboplastin times. Subsequently, 
fever, body tenderness and inflammatory markers were 
improved after three weeks, and the dose of predniso-
lone was gradually increased by 2.5-mg increments from 
5 mg/week to 20 mg/day, and was then further tapered 
by 2.5-mg increments every three weeks to 10 mg/day. 
Follow-up MRA showed improved signal intensity in bi-
lateral anterior cerebral arteries (ACAs) and middle ce-
rebral arteries (MCAs), whereas contrast-enhanced MRI 
demonstrated persistent wall enhancement in bilateral 
ICAs. The patient showed neurological symptoms, such 
as moria, emotional incontinence, grasp reflex, right 
hemiparesis and left hemiplegia, and was transferred 
to a rehabilitation center at 15 weeks after administra-
tion. Contrast-enhanced MRI at six months after onset 
revealed persistent wall enhancement in bilateral ICAs. 
However, no stroke recurrence has been identified with 
continuing to take small doses of prednisolone (less than 
10 mg/day) during four years of follow-up. 
DISCUSSION
The present patient experience indicates that arteritis can 
be limited to the ICA. In addition, the patient was: i) a 
young woman; ii) had wall enhancements in contrast-en-
hanced MRI; iii) responded to steroid therapy and iv) 
was positive for the serotypes HLA-B39, -B51 and -DR4. 
 In contrast with exiting disease concepts, arteritis 
was caused by autoimmune disease in the present case, 
according to contrast-enhanced MRI findings and the 
efficacy of steroid therapy. Moreover, although we did 
not observe symptoms or organ involvements, autoanti-
bodies indicated autoimmune disease such as systemic 
lupus erythematosus and medium- or small-vessel vas-
culitis, and the lesion was primarily located in bilateral 
ICAs. Based on these findings, we suspected TAK or 
GCA, both of which are types of large-vessel vasculitis 
or Behçet’s disease, which induces lesions in large–
small arteries. We also considered tuberculosis because 
a tuberculosis patient reportedly developed infectious 
vasculitis with a primary lesion in the ICA.2 However, 
tuberculosis was not evident in the present case.
 Cerebral infarction is an accepted diagnostic marker 
of TAK.3 Although intracranial artery lesions are rare 
complications, the presence of such lesions has been ob-
served previously using angiography, and in biopsies.4, 5 
However, to the best of our knowledge, no reports have 
described TAK cases with primary lesions at the ICA, 
and no reported TAK cases presented with aortic lesions 
after follow-up surveillance of ICA lesions that devel-
oped during the early stages of disease. The present pa-
tient was a young woman and exhibited symptoms that 
were suggestive of TAK, including bilateral blood pres-
sure differences and the presence of HLA-B39. Howev-
er, the absence of lesions in the aorta or at the proximal 
region of the first branch precluded diagnosis of TAK.
 Numerous reports describe GCA primarily at the 
ICA.6–14 Although onset at a young age is extremely rare, 
pathologically demonstrated GCA has been reported in 
patients of more than 50 years of age.15–17 However, STA 
biopsy examinations can produce false-negative diagno-
ses, and even after identification of negative biopsies on 
one side, only 3 to 10% of biopsies on the contralateral 
side reportedly result in positive findings.18 
 Atypical presentations of GCA have been reported 
in previous case studies, and the present observations, 
including histology of the primary lesion site, symp-
tomatic headaches, augmented ESR and the presence of 
HLA-DR4, are indicative of GCA. However, the present 
case was not diagnosed with GCA according to diagnos-
tic criteria, because onset occurred at a young age and 
no temporal artery anomalies or artery biopsy abnor-
malities were observed.
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Table 1. Reported cases of non-infectious arteritis predominantly affecting the ICA, without involvement of 
intracranial arteries (except ICA and vertebral artery), aortas or proximal aortic branches
Authors (Refer-
ence number) Year
Age (years)
/ Sex Diagnosis Antibody
Stenosis/
Occlusion Modality Pathology Treatment
Prognosis
/Prevention
Wilkinson 1 
(8) 1972 74/ Male GCA ND
Bil. ICA, 
Bil. VA Autopsy
Biopsy STA 
(+), Autopsy PSL
Died on the day of 
admission/ND
Wilkinson 2 
(8) 1972 80/ Male GCA ND
Bil. ICA, 
Bil. VA Autopsy
Biopsy STA 
(+), Autopsy PSL
Died 6 days after 
admission/ ND
Wilkinson 3 
(8) 1972 79/ Male GCA ND
Bil. ICA, 
Bil. VA Autopsy
Biopsy STA 
(+), Autopsy PSL Died/ND
Wilkinson 4 
(8) 1972 75/ Male GCA ND
Bil. ICA, 
Bil. VA Autopsy
Autopsy 
STA (+) PSL
Died 6 days after 
admission/ND
Cull 
(6) 1979 46/ Female GCA Negative Rt. ICA Angiography
Biopsy STA 
(+) PSL Alive/PSL
Howard 
(9) 1984 65/ Female GCA Negative Bil. ICA Autopsy
Autopsy 
ICA (+) Unknown
Died 33 days after 
admission/ND
Bogousslavsky 
(10) 1985 60/ Male GCA ND Bil. ICA Autopsy
Autopsy 
ICA (+)
Dexametha-
sone
Died 12 days after 
admission/ND
Vincent 
(7) 1986 60/ Female GCA ND Bil. ICA Angiography
Biopsy STA 
(+) PSL, Aspirin Alive 3 Y later/PSL
Gonzalez 
(11) 1998 65/ Female GCA aCL Ab Lt. ICA Angiography
Biopsy STA 
(+) PSL, Aspirin
Alive 5 Y later/As-
pirin
Thielen 
(12) 1998 69/ Female GCA
Antinu-
clear Ab
Bil. ICA, 
Lt. VA Angiography
Biopsy STA 
(+) Steroid Alive 15M later/ND
Noguchi 
(23) 1999 76/ Female GCA Negative
Bil. ICA, 
Bil. ECA Angiography
Biopsy STA 
(+)
Steroid, AP, 
AC
Alive 2 Y later/
PSL, AP
Takekawa
 (24) 2008 56/ Male GCA ND Bil. ICA Angiography Unknown PSL
Improvement of 
MRA findings/ND
Solans-Laque 
(13) 2008 90/ Male GCA ND Lt. ICA
US/CTA/
MRA
Biopsy STA 
(+)
mPSL, PSL, 
AP, AC
Alive 40 M later/
PSL, AP
Lu-Emerson1 
(14) 2010 64/ Female GCA ND
Bil. ICA, 
Bil. VA Angiography
Biopsy STA 
(+), Autopsy
Steroid, 
Aspirin, CPA, 
Rituximab
Stepwise decline 
and died 2 Y later/
ND
Lu-Emerson 2 
(14) 2010 65/ Male GCA ND
Bil. ICA, 
Bil. VA Angiography
Biopsy STA 
(+)
AP, intraar-
terial stent 
placement , 
Steroid, CPA
Stepwise decline 
and died 7 M later/
ND
Logar
 (21) 1994 32/ Female GPA
PR3-
ANCA Bil. ICA Angiography
Biopsy 
Kidney (+)
mPSL, PSL, 
CPA
Improvement of 
laboratory Find-
ings/ND
Schmidt 
(22) 2001 37/ Male GPA
PR3-
ANCA Lt. ICA
US, MRA, 
Angiography
Biopsy 
Kidney (+)
PSL, CPA, 
Aspirin
Improvement of 
laboratory findings/
ND
Present case 38/ Female Undeter-mined Negative Bil. ICA
US, MRA, 
Angiography
Biopsy STA 
(−) AP, AC, PSL
Alive 3 Y later/
PSL, AP
Autopsy (+)” or “Biopsy (+)” indicates the presence of pathological findings which support the diagnosis: giant cell, granulomas or others.
Ab, antibody; AC, anti-coagulant drug; aCL, anticardiolipin; AP, anti-platelet drug; Bil, bilateral; CPA, cyclophosphamide; CTA, comput-
ed tomography angiography; ECA, external carotid artery; GCA, giant cell arteritis; GPA, granulomatosis with polyangiitis; ICA, internal 
carotid artery; Lt, left; M, months; mPSL, methylprednisolone; MRA, magnetic resonance angiography; ND, no description; PR3-AN-
CA, proteinase 3-antineutrophil cytoplasmic antibody; PSL, prednisolone; Rt, right; STA, superficial temporal artery; US, ultrasonogra-
phy; VA, vertebral artery; W, weeks; Y, years.
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 Clinical hallmarks of GCA, including the presen-
tation of vasculitis of the temporal artery and the intra-
cranial artery (cranial GCA), and arteritis of the aorta 
or first branch [large-vessel GCA (LV-GCA)], have been 
specified as clinical presentations of classical temporal 
arteritis (TA).19 Moreover, LV-GCA is observed in 10 to 
15% of all GCA cases, and reportedly presents as lesions 
in the aorta, carotid arteries and subclavian arteries in 
the absence of TA in biopsies. In addition, both GCA 
and TAK are characterized by histopathological forma-
tions of granulomatous lesions, and TAK and LV-GCA 
exhibit similarities in affected vessel morphology, histo-
pathology and clinical symptoms, suggesting inclusion 
within the same disease spectrum.20 However, although 
temporal artery biopsy resulted in negative findings in 
the present case, the clinical spectrum for the affected 
vessel did not coincide with that of LV-GCA.
 Lesions of any size can occur in Behçet’s disease 
and predominantly affect veins rather than arteries. Typ-
ically, vasculo-Behçet’s disease occurs several years af-
ter the onset of Behçet’s disease. The present patient was 
HLA-B51-positive and the affected vessel was somewhat 
consistent with Behçet’s disease. However, because 
whole-body symptoms of Behçet’s disease and vein 
lesions were not observed, Behçet’s disease was consid-
ered unlikely. The present patient was diagnosed with a 
form of non-infectious vasculitis with atypical clinical 
presentation, and after consideration of large-vessel vas-
culitis diseases TAK and GCA, Behçet’s disease criteria 
were examined. However, the present patient conditions 
were not sufficiently consistent with any of these dis-
eases, and the patient was diagnosed as having a type of 
vasculitis with primary lesions in the ICA that was on 
the disease spectrum of TAK and GCA, but with differ-
ent clinical presentation. 
 In comparison with the 17 previously reported cases 
of ICA arteritis,6–14, 21, 22 distinguishing characteristics 
of the present female case included relative youth, wall 
enhancement on contrast-enhanced MRI, therapeutic 
effects of steroids and the presence of HLA serotypes 
(HLA-B39, -B51 and -DR4) (Table 1). Fifteen of these 
cases were diagnosed with GCA6–14 and the remaining 
2 cases had granulomatosis with polyangiitis (GPA).21, 22 
Although these two GPA cases had onset at a young age, 
renal lesions and proteinase 3-antineutrophil cytoplasmic 
antibody (PR3-ANCA) expression were not consistent 
with the present case. Another previous case described 
a patient with autoimmune disease who developed ICA 
lesions25; however, the distributions of vascular lesions 
were dissimilar to those in the present case. Thus, none 
of the 17 cases presented the clinical characteristics that 
were consistent with the present case. 
 The relative youth and gender of the present case 
was nearly in accordance with one GCA case6 and one 
GPA case.21 However, wall enhancement on contrast-en-
hanced MRI was not described for any of the previously 
reported 17 cases, despite its correlation with serum 
markers of disease activity, and its utility for assess-
ments of mural inflammation in GCA and TAK.26–28 
Although enhanced MRI facilitates primary diagnosis 
of TA, a recent study suggested that assessments of wall 
enhancement are limited indicators of disease activity in 
long-term follow-up of TA.29 In agreement, contrast-en-
hanced T1-weighted MRI assessments of the ICA were 
of diagnostic value in the present case, with wall en-
hancement on admission not only from a retrospective 
viewpoint (Figs. 2A1 and A2) but also after symptoms 
and inflammatory markers were improved by predniso-
lone therapy (Figs. 2C1 and C2). Hence, persistent vessel 
wall enhancement may not always indicate increased 
disease activity.
 Steroids, immunosuppressants or antithrombotic 
agents are common as acute and preventive therapy for 
clinical vasculitis,6–14, 21, 22 and are used in combination 
for cases with favorable prognoses. Combined prednis-
olone and antithrombotic treatments were successful as 
acute therapy in the present case, and subsequent low-
dose prednisolone and antiplatelet therapy prevented 
further strokes. Hence, combination immune and an-
tithrombotic therapy should be considered for arteritis 
involving cervical and cerebral arteries.
 Finally, onset of vasculitis has been associated with 
environmental and genetic factors and various correla-
tions between vasculitis and HLA alleles have been 
elucidated. Specifically, TAK is reportedly associated 
with HLA-B52 (B*5201) and -B39 (B*3902),30 whereas 
Behçet’s disease is associated with HLA-B51 (B*5101),31 
GCA is associated with HLA-DR4 (DRB1*04), cranial 
GCA is associated with DRB1*0401, and large-vessel 
GCA is associated with DRB1*0404.19 In the present 
case, the HLA serotypes HLA-B39, -B51 and -DR4 
were identified without HLA allele typing, unprecedent-
edly suggesting Behçet’s disease, TAK and GCA, re-
spectively. In contrast, no HLA serotypes or alleles were 
reported in the aforementioned 17 cases.6–14, 21, 22 Thus, 
further accumulations of HLA typing in similar cases 
are required to evaluate these associations. 
 In summary, the present case was distinguished 
from previous cases by relative youth and contrast-en-
hanced MRI and HLA characteristics. 
 Here we report a rare evidence of arteritis limited to 
ICA in an unprecedented case of a young woman with 
wall enhancement on contrast-enhanced MRI, thera-
peutic effects of steroids, and HLA serotypes HLA-B39, 
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-B51 and -DR4. These disease characteristics were not in 
accordance with existing diagnostic criteria, warranting 
consideration of a novel “isolated internal carotid arteri-
tis” disease concept.
The authors declare no conflict of interest.
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